but not as bad as the share price shows, imho.
http://www.oxfordbiomedica.co.uk/pag...=59&newsid=302
The patient number is so small (15 in total), that the results can skewed by one persons adversely positive or negative feelings on the day.
With something as "personal" as PD, in the current testing set-up it makes you wonder how we will ever know if Prosavin or others work or not.
Ho hum,
Neil.